Télécharger le supplément (250 p.) - KCE

More documents

Recommendations

Info

106 Médecine à l'acte / médecine au forfait - ANNEXES KCE Reports 85 S Parameter Estimate Standard Error t Value Pr > |t| age*inv 1-4 ans 2 0.000000 B . . . age*inv 25-39 ans 1 3507.096609 B 2253.535545 1.56 0.1197 age*inv 25-39 ans 2 0.000000 B . . . age*inv 40-64 ans 1 -240.342292 B 2221.266227 -0.11 0.9138 age*inv 40-64 ans 2 0.000000 B . . . age*inv 5-24 ans 1 -3264.132531 B 2232.783048 -1.46 0.1438 age*inv 5-24 ans 2 0.000000 B . . . age*inv 65-74 ans 1 1618.199022 B 2993.816321 0.54 0.5888 age*inv 65-74 ans 2 0.000000 B . . . age*inv 75-84 ans 1 0.000000 B . . . age*inv 75-84 ans 2 0.000000 B . . . age*inv 85-+ ans 2 0.000000 B . . . age*aidsoc 1-4 ans 2 0.000000 B . . . age*aidsoc 25-39 ans 1 -5471.801612 B 2016.840058 -2.71 0.0067 age*aidsoc 25-39 ans 2 0.000000 B . . . age*aidsoc 40-64 ans 1 -5954.462544 B 2009.095811 -2.96 0.0030 age*aidsoc 40-64 ans 2 0.000000 B . . . age*aidsoc 5-24 ans 1 -5514.360143 B 2041.300449 -2.70 0.0069 age*aidsoc 5-24 ans 2 0.000000 B . . . age*aidsoc 65-74 ans 1 -6075.516362 B 2068.161683 -2.94 0.0033 age*aidsoc 65-74 ans 2 0.000000 B . . . age*aidsoc 75-84 ans 1 -5889.858769 B 2174.766578 -2.71 0.0068 age*aidsoc 75-84 ans 2 0.000000 B . . . age*aidsoc 85-+ ans 1 0.000000 B . . . age*aidsoc 85-+ ans 2 0.000000 B . . . im*chom3 1 1 -1202.373187 B 332.558644 -3.62 0.0003 im*chom3 1 2 0.000000 B . . . im*chom3 2 1 0.000000 B . . . im*chom3 2 2 0.000000 B . . . inv*PP0020 1 1 1152.743798 B 313.127770 3.68 0.0002 inv*PP0020 1 2 0.000000 B . . . inv*PP0020 2 1 0.000000 B . . . inv*PP0020 2 2 0.000000 B . . . inv*aidsoc 1 1 2751.482363 B 1152.796374 2.39 0.0170 inv*aidsoc 1 2 0.000000 B . . . inv*aidsoc 2 1 0.000000 B . . . inv*aidsoc 2 2 0.000000 B . . . The X'X matrix has been found to be singular, and a generalized inverse was used to solve the normal equations. Terms whose estimates are followed by the letter 'B' are not uniquely estimable. Essai 3 : en enlevant les intéractions non significatives Class Level Information Class Levels Values age 7 1-4 ans 25-39 ans 40-64 ans 5-24 ans 65-74 ans 75-84 ans 85-+ ans im 2 1 2 inv 2 1 2 PP0020 2 1 2 prep 2 1 2 VPO 2 1 2 chom3 2 1 2 aidsoc 2 1 2 Number of Observations Read 21778 Number of Observations Used 21778 Source DF Sum of Squares Mean Square F Value Pr > F Model 27 36930032817 1367778993.2 47.79
KCE Reports 85 S Médecine à l’acte/médecine au forfait – ANNEXES 107 R-Square Coeff Var Root MSE cat Mean 0.056003 419.2257 5349.837 1276.123 Source DF Type I SS Mean Square F Value Pr > F age 6 14183739683 2363956614 82.60
Page 1 and 2:
Comparaison du coût et de la quali
Page 3 and 4:
Comparaison du coût et de la quali
Page 5 and 6:
KCE Reports 85 S Médecine à l’a
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60: KCE Reports 85 S Médecine à l’a
Page 109: KCE Reports 85 S Médecine à l’a
Page 113 and 114: KCE Reports 85 S Médecine à l'act
Page 161 and 162:
KCE Reports 85 S Médecine à l'act
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
This page is left intentionally bla
Page 247 and 248:
KCE reports 1. Efficacité et renta
Page 249:
74. Oxygénothérapie Hyperbare: Ra
show all

Télécharger le supplément (250 p.) - KCE

Create successful ePaper yourself

Delete template?

Save as template?